6 results  1 of 1 

1 Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Soon-Jib Yoo, Sang-Ah Chang, Tae Seo Sohn, Hyuk-Sang Kwon, Jong Min Lee, Sungdae Moon, Pieter Proot, Päivi M Paldánius, Kun Ho Yoon
Diabetes Metab J.2021;45(6):954-959.   Published online 2020 November 12     DOI: http://dx.doi.org/10.4093/dmj.2020.0173
      
2 Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot Study
Jaehyun Bae, Min Jung Lee, Eun Yeong Choe, Chang Hee Jung, Hye Jin Wang, Myoung Soo Kim, Yu Seun Kim, Joong-Yeol Park, Eun Seok Kang
Endocrinol Metab.2016;31(1):161-167.   Published online 2016 March 16     DOI: http://dx.doi.org/10.3803/EnM.2016.31.1.161
      
3 The Effect of Vildagliptin on Visfatin in Korean Patients with Type 2 Diabetes: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Prospective Study
Young Hwan Jang, Dong Hyun In, Jae Kook Yang, Hyuk Jin Moon, Gyu Tae Yoon, Ah Jeong Ryu, Yeo Joo Kim, Eun Young Lee, Hyun Jin Kim, Bon Jeong Ku, Jae Min Lee, Kang Seo Park, In Suk Lee, Jong Min Lee, Dong Mee Lim, Keun Yong Park, Sang Jin Kim
J Korean Diabetes.2015;16(4):303-309.   Published online 2015 January 10     DOI: http://dx.doi.org/10.4093/jkd.2015.16.4.293
   
4 Predictive Clinical Parameters and Glycemic Efficacy of Vildagliptin Treatment in Korean Subjects with Type 2 Diabetes
Jin-Sun Chang, Juyoung Shin, Hun-Sung Kim, Kyung-Hee Kim, Jeong-Ah Shin, Kun-Ho Yoon, Bong-Yun Cha, Ho-Young Son, Jae-Hyoung Cho
Diabetes Metab J.2013;37(1):72-80.   Published online 2013 February 15     DOI: http://dx.doi.org/10.4093/dmj.2013.37.1.72
      
5 Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
Hyun Jeong Jeon, Tae Keun Oh
Diabetes Metab J.2011;35(5):529-535.   Published online 2011 October 31     DOI: http://dx.doi.org/10.4093/dmj.2011.35.5.529
      
6 DPP-4 Inhibitors and the Relations between Rosiglitazone and the Risk of Myocardial Infarction
Hyoung Woo Lee
J Korean Med Assoc.2008;51(4):371-376.   Published online 2008 April 30     DOI: http://dx.doi.org/10.5124/jkma.2008.51.4.371
      

 1 of 1